Grants and Contributions:
Title:
Enhancing Canadian Innovation in Biomanufacturing and R&D in mRNA Medicines
Agreement Number:
819773
Agreement Value:
$49,900,000.00
Agreement Date:
May 23, 2024 - Jan 1, 2044
Description:
Enhancing Canadian Innovation in Biomanufacturing and R&D in mRNA Medicines
Organization:
Innovation, Science and Economic Development Canada
Location:
Calgary, Alberta, CA T2J3J1
Reference Number:
033-2024-2025-Q1-819773
Agreement Type:
Other transfer payment
Report Type:
Grants and Contributions
Recipient Business Number:
738045079
Recipient Type:
For-profit organization
Additional Information:
Agreement Type is PRC, 2022/23 to 2026/27,
Recipient's Operating Name:
Providence Therapeutics Holdings Inc.
Recipient's Legal Name:
Providence Therapeutics Holdings Inc.
Federal Riding Name:
Calgary Midnapore
Federal Riding Number:
48008
Program:
SIF Stream2- Growth
Program Purpose:
-Encourage R&D that will accelerate technology transfer and commercialization of innovative products, processes and services;-Facilitate the growth and expansion of firms in Canada;-Attract and retain large scale investments to Canada; and-Advance industrial research, development and technology demonstration through collaboration between academia, non-profit organizations and the private sector.
NAICS Code:
339900